These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7595560)

  • 21. Endogenous synthesis of N-methyl-1,2,3,4-tetrahydroisoquinoline, a precursor of N-methylisoquinolinium ion, in the brains of primates with parkinsonism after systemic administration of 1,2,3,4-tetrahydroisoquinoline.
    Niwa T; Yoshizumi H; Tatematsu A; Matsuura S; Yoshida M; Kawachi M; Naoi M; Nagatsu T
    J Chromatogr; 1990 Nov; 533():145-51. PubMed ID: 2127934
    [No Abstract]   [Full Text] [Related]  

  • 22. Biochemical and pathological study of endogenous 1-benzyl-1,2,3,4-tetrahydroisoquinoline-induced parkinsonism in the mouse.
    Abe K; Taguchi K; Wasai T; Ren J; Utsunomiya I; Shinohara T; Miyatake T; Sano T
    Brain Res; 2001 Jul; 907(1-2):134-8. PubMed ID: 11430895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of 1-methyl-1,2,3,4-tetrahydroisoquinoline in mouse brain after treatment with haloperidol by gas chromatography-selected ion monitoring.
    Igarashi K; Sugiyama Y; Kasuya F; Saiki K; Yamakawa T; Ohata S
    J Chromatogr B Biomed Sci Appl; 1999 Aug; 731(1):53-8. PubMed ID: 10491989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline, a Parkinsonism-inducing endogenous toxin, increases alpha-synuclein expression and causes nuclear damage in human dopaminergic cells.
    Shavali S; Carlson EC; Swinscoe JC; Ebadi M
    J Neurosci Res; 2004 May; 76(4):563-71. PubMed ID: 15114628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel endogenous 1,2,3,4-tetrahydroisoquinoline derivatives: uptake by dopamine transporter and activity to induce parkinsonism.
    Kawai H; Makino Y; Hirobe M; Ohta S
    J Neurochem; 1998 Feb; 70(2):745-51. PubMed ID: 9453570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism and brain accumulation of tetrahydroisoquinoline (TIQ) a possible parkinsonism inducing substance, in an animal model of a poor debrisoquine metabolizer.
    Ohta S; Tachikawa O; Makino Y; Tasaki Y; Hirobe M
    Life Sci; 1990; 46(8):599-605. PubMed ID: 2308469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biosynthesis of 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ), a possible antiparkinsonism agent.
    Tasaki Y; Makino Y; Ohta S; Hirobe M
    Adv Neurol; 1993; 60():231-3. PubMed ID: 8420139
    [No Abstract]   [Full Text] [Related]  

  • 28. Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds. 1,2,3,4-Tetrahydroisoquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline.
    Kikuchi K; Nagatsu Y; Makino Y; Mashino T; Ohta S; Hirobe M
    Drug Metab Dispos; 1991; 19(1):257-62. PubMed ID: 1673411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in parkinsonian and normal human brains.
    Niwa T; Takeda N; Kaneda N; Hashizume Y; Nagatsu T
    Biochem Biophys Res Commun; 1987 Apr; 144(2):1084-9. PubMed ID: 3579928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tetrahydroisoquinolines in connection with Parkinson's disease].
    Ohta S
    Rinsho Shinkeigaku; 1989 Dec; 29(12):1504-6. PubMed ID: 2698297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties.
    Antkiewicz-Michaluk L; Michaluk J; Mokrosz M; Romanska I; Lorenc-Koci E; Ohta S; Vetulani J
    J Neurochem; 2001 Jul; 78(1):100-8. PubMed ID: 11432977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of tetrahydroisoquinoline (TIQ), one of endogenous substances inducing parkinsonism, on isolated rat vas deferens.
    Koike K; Takayanagi I; Wani S; Yanagita T; Ohta S; Hirobe M
    Gen Pharmacol; 1989; 20(2):259-60. PubMed ID: 2714622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Not Just from Ethanol. Tetrahydroisoquinolinic (TIQ) Derivatives: from Neurotoxicity to Neuroprotection.
    Peana AT; Bassareo V; Acquas E
    Neurotox Res; 2019 Nov; 36(4):653-668. PubMed ID: 31049880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presence of tetrahydroisoquinoline, a parkinsonism-related compound, in foods.
    Niwa T; Yoshizumi H; Tatematsu A; Matsuura S; Nagatsu T
    J Chromatogr; 1989 Sep; 493(2):347-52. PubMed ID: 2584300
    [No Abstract]   [Full Text] [Related]  

  • 35. Detection of tetrahydroisoquinoline in parkinsonian brain as an endogenous amine by use of gas chromatography-mass spectrometry.
    Niwa T; Takeda N; Sasaoka T; Kaneda N; Hashizume Y; Yoshizumi H; Tatematsu A; Nagatsu T
    J Chromatogr; 1989 Jul; 491(2):397-403. PubMed ID: 2808624
    [No Abstract]   [Full Text] [Related]  

  • 36. A metabolic approach to the detection of tetrahydroisoquinoline formation from 3H-dopamine in rat brain following treatment with ethanol or chloral hydrate.
    Shier WT; Koda LY; Bloom FE
    Prog Clin Biol Res; 1982; 90():191-200. PubMed ID: 7111319
    [No Abstract]   [Full Text] [Related]  

  • 37. Presence of methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines, derivatives of the neurotoxin isoquinoline, in parkinsonian lumbar CSF.
    Moser A; Kömpf D
    Life Sci; 1992; 50(24):1885-91. PubMed ID: 1598074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presence of tetrahydroisoquinoline and 1-methyl-tetrahydro-isoquinoline in foods: compounds related to Parkinson's disease.
    Makino Y; Ohta S; Tachikawa O; Hirobe M
    Life Sci; 1988; 43(4):373-8. PubMed ID: 3398705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation of 1-methyl-1,2,3,4-tetrahydroisoquinoline-synthesizing enzyme from rat brain: a possible Parkinson's disease-preventing enzyme.
    Yamakawa T; Ohta S
    Biochem Biophys Res Commun; 1997 Jul; 236(3):676-81. PubMed ID: 9245712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concentration-dependent opposite effects of 1-benzyl-1,2,3,4-tetrahydroisoquinoline on markers of apoptosis: in vitro and ex vivo studies.
    Wąsik A; Kajta M; Lenda T; Antkiewicz-Michaluk L
    Neurotox Res; 2014 Jan; 25(1):90-9. PubMed ID: 24190811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.